PMC Links for Books (Select 4403670) - PMC

Select item 84033051.

Association of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID‐19

Rohan Khera, Callahan Clark, Yuan Lu, Yinglong Guo, Sheng Ren, Brandon Truax, Erica S. Spatz, Karthik Murugiah, Zhenqiu Lin, Saad B. Omer, Deneen Vojta, Harlan M. Krumholz

J Am Heart Assoc. 2021 Jul 6; 10(13): e018086. Published online 2021 Jun 16. doi: 10.1161/JAHA.120.018086

PMCID:: PMC8403305

Article PDF–2.9M

Select item 82632582.

Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials

Jia Yao, Simin Fan, Xiaoyan Shi, Xiayu Gong, Jia Zhao, Guanjie Fan

PLoS One. 2021; 16(7): e0253492. Published online 2021 Jul 7. doi: 10.1371/journal.pone.0253492

PMCID:: PMC8263258

Article PDF–1.2M

Select item 65836063.

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury

Sandeep Brar, Feng Ye, Matthew T. James, Brenda Hemmelgarn, Scott Klarenbach, Neesh Pannu

JAMA Intern Med. 2018 Dec; 178(12): 1681–1690. Published online 2018 Oct 27. doi: 10.1001/jamainternmed.2018.4749

PMCID:: PMC6583606

Article

Select item 65169954.

First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension

Yu Jie Chen, Liang Jin Li, Wen Lu Tang, Jia Yang Song, Ru Qiu, Qian Li, Hao Xue, James M Wright, Cochrane Hypertension Group

Cochrane Database Syst Rev. 2018; 2018(11): CD008170. Published online 2018 Nov 14. doi: 10.1002/14651858.CD008170.pub3

PMCID:: PMC6516995

Article PDF–1.0M

Select item 62878675.

The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial

Valeria Saglimbene, Suetonia C. Palmer, Marinella Ruospo, Patrizia Natale, Ausilia Maione, Antonio Nicolucci, Mariacristina Vecchio, Gianni Tognoni, Jonathan C. Craig, Fabio Pellegrini, Giuseppe Lucisano, Jörgen Hegbrant, Rosario Ariano, Olga Lamacchia, Antonio Sasso, Susanna Morano, Tiziana Filardi, Salvatore De Cosmo, Giuseppe Pugliese, Deni A. Procaccini, Loreto Gesualdo, Giuseppe Palasciano, David W. Johnson, Marcello Tonelli, Giovanni F.M. Strippoli, on behalf of the Long-Term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) Investigators

J Am Soc Nephrol. 2018 Dec; 29(12): 2890–2899. Published online 2018 Nov 12. doi: 10.1681/ASN.2018040443